Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2023-04-17 00:00:00 ET · period of report 2023-04-10 · accession 0001683168-23-002424 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | 2023-04-10 | CNSP | Gumulka Jerzy | Dir | P - Purchase | $0.74 | +7,173 | 7,173 | New | +$5,308 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-10 | P | A | 7,173 | $0.74 | 7,173 | D | — | — |